tirzepatide for sleep apnea fda approval Approves (Zepbound) as the First Medication Obstructive Breakthrough Treatment for Obstructive Sleep
Description
This can lead to further calorie expenditure, enhanced fitness levels, and better overall well-being
Hocking S, Scott D, Remedios M
When a medication reaches millions of people and a meaningful subset of those people report serious harm, the question of whether the manufacturer met its duty to inform becomes a legitimate one for courts to evaluate
[Google Scholar] [100].Henry RR, Logan D, Alessi T, Baron MA, A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes, Clinical therapeutics, 35 (2013) 634645 e631
